MaveriX Oncology - Crunchbase Company Profile & Funding

Q: Who invested in MaveriX Oncology?

MaveriX Oncology has 2 investors including Sotio And PPF Group.

Q: When was the last funding round for MaveriX Oncology?

MaveriX Oncology closed its last funding round on obfuscated from a Series A round.

Q: How much funding has MaveriX Oncology raised to date?

MaveriX Oncology has raised obfuscated.

Overview

MaveriX Oncology

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About MaveriX Oncology

CB Rank

92742

MaveriX Oncology is a globally-orientated biotechnology company.

Founded

obfuscation

Private

Series A

Palo Alto, California, United States

1-10

www.maverixoncology.com/

Biotechnology

Health Care

Oncology

Therapeutics

Funding Rounds

Series A

OBF

obfuscation

Key People

Chris Bowers: COO
Past Role: Green EnviroTech Holdings, CEO & Director
Steven Everett: Founder, President & CEO

Details

Legal Name

MaveriX Oncology, Inc.

Operating Status

Active

Company Type

For Profit

Founders

Steven Everett

About the Company

MaveriX is a globally-orientated biotechnology company focused on the discovery, development, and commercialization of targeted small-molecule cancer chemo-immunotherapies.Their technology approach leverages unexploited insights into cancer and immune cell metabolism within the tumor microenvironment which are common to all cancers.

Contact Email

info@maverixoncology.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

IMPACT-2X

A hydroxylase-releasable masking technology used to create tumor-specific conditionally activated-small molecule drug conjugates for treating solid tumors.

CA-SMDCs

Conditionally activated-small molecule drug conjugates designed to selectively target tumors, minimizing impact on healthy tissue.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - MaveriX Oncology	2	obfuscated obfuscation	PPF Group	Series A
obfuscated obfuscation	Series A - MaveriX Oncology	2	obfuscated obfuscation	PPF Group	Series A
obfuscated obfuscation	Series A - MaveriX Oncology	2	obfuscated obfuscation	PPF Group	Series A
obfuscated obfuscation	Series A - MaveriX Oncology	2	obfuscated obfuscation	PPF Group	Series A
obfuscated obfuscation	Series A - MaveriX Oncology	2	obfuscated obfuscation	PPF Group	Series A

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - MaveriX Oncology	2	obfuscated obfuscation	PPF Group	Series A
obfuscated obfuscation	Series A - MaveriX Oncology	2	obfuscated obfuscation	PPF Group	Series A
obfuscated obfuscation	Series A - MaveriX Oncology	2	obfuscated obfuscation	PPF Group	Series A
obfuscated obfuscation	Series A - MaveriX Oncology	2	obfuscated obfuscation	PPF Group	Series A
obfuscated obfuscation	Series A - MaveriX Oncology	2	obfuscated obfuscation	PPF Group	Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Sotio	—	Series A - MaveriX Oncology	Radek Spisek
Sotio	—	Series A - MaveriX Oncology	Radek Spisek
Sotio	—	Series A - MaveriX Oncology	Radek Spisek
Sotio	—	Series A - MaveriX Oncology	Radek Spisek
Sotio	—	Series A - MaveriX Oncology	Radek Spisek